Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Recent Advances With Liposomes As Pharmaceutical Carriers

V. Torchilin
Published 2005 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Liposomes — microscopic phospholipid bubbles with a bilayered membrane structure — have received a lot of attention during the past 30 years as pharmaceutical carriers of great potential. More recently, many new developments have been seen in the area of liposomal drugs — from clinically approved products to new experimental applications, with gene delivery and cancer therapy still being the principal areas of interest. For further successful development of this field, promising trends must be identified and exploited, albeit with a clear understanding of the limitations of these approaches.
This paper references
10.1097/01.CCM.0000109774.99665.22
Hemoglobin-vesicles suspended in recombinant human serum albumin for resuscitation from hemorrhagic shock in anesthetized rats*
H. Sakai (2004)
10.3109/10731199909117481
Complement-mediated acute effects of liposome-encapsulated hemoglobin.
J. Szebeni (1999)
Epidermal growth factor receptor ( EGFR )targeted immunoliposomes mediate specific and efficient drug delivery to EGFRand EGFRvIIIoverexpressing tumor cells
C. Mamot (2003)
10.3892/IJO.18.1.121
Targeted systemic chemotherapy using magnetic liposomes with incorporated adriamycin for osteosarcoma in hamsters.
T. Kubo (2001)
imaging of experimental myocardial infarction
Khaw (1984)
10.1021/BC990031N
New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine.
S. Zalipsky (1999)
10.1016/S0021-9673(00)94549-7
Liposomally entrapped adenosine triphosphate. Improved efficiency against experimental brain ischaemia in the rat.
A. Laham (1988)
10.1002/JPS.1115
In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide.
C. F. Lange (2001)
10.1148/RADIOL.2223010861
Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model.
S. Goldberg (2002)
supramolecular assembly and gene delivery
Safinya (2001)
10.1021/BC970183N
Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
H. Guan (1998)
10.1016/J.IJPHARM.2004.05.025
Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo.
H. Hatakeyama (2004)
10.1021/BI035802W
Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Tomoyuki Kakudo (2004)
Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors.
A. Gonçalves (2003)
10.1007/s005950170132
Antimetastatic Effect of Hepatotropic Liposomal Adriamycin on Human Metastatic Liver Tumors
I. Matsuda (2001)
Cationic liposome-mediated transfection.
P. Felgner (1989)
10.1021/BC020089T
Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
C. P. Leamon (2003)
10.1023/A:1010960900254
Liposomes Bearing Polyethyleneglycol-Coupled Transferrin with Intracellular Targeting Property to the Solid Tumors In Vivo
O. Ishida (2004)
Adenosine triphosphate liposomes: encapsulation and distribution studies.
G. Xu (1990)
10.1016/S0005-2736(01)00441-2
Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.
M. Turk (2002)
10.1016/S0169-409X(97)00136-1
Controlling liposome blood clearance by surface-grafted polymers.
Woodle (1998)
10.1081/CNV-120014883
Pegylated Liposomal Doxorubicin (Doxil®) for Metastatic Breast Cancer: The Cancer Research Network, Inc., Experience
A. Perez (2002)
10.1016/1357-4310(96)88805-8
Liposomes as delivery agents for medical imaging.
V. Torchilin (1996)
10.1016/J.ADDR.2004.01.011
Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates.
A. Gabizon (2004)
Thrombolytic treatment with tissuetype plasminogen activator ( tPA ) containing liposomes in rabbits : a comparison with free tPA
J. L. Heeremans (1995)
10.2174/1567201043480063
ATP-containing immunoliposomes specific for cardiac myosin.
W. Liang (2004)
10.1002/(SICI)1097-4636(200007)51:1<10::AID-JBM2>3.0.CO;2-R
Targeted drug delivery to C6 glioma by transferrin-coupled liposomes.
D. A. Eavarone (2000)
10.1016/S0076-6879(03)73034-1
Cationic liposome-mediated gene delivery in vivo.
Y. Liu (2003)
Oral colonspecific drug delivery for bee venom peptide : development of a coated calcium alginate gel beadsentrapped liposome
L. Xing (2003)
10.1124/MOL.62.4.864
Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study.
Yun-Long Tseng (2002)
Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute.
W. Phillips (1999)
10.1016/J.JCONREL.2003.12.023
Liposome transduction into cells enhanced by haptotactic peptides (Haptides) homologous to fibrinogen C-termini.
R. Gorodetsky (2004)
10.1016/S0083-6729(00)60022-5
Liposome targeting to tumors using vitamin and growth factor receptors.
D. Drummond (2000)
10.1007/s15010-004-3147-4
Rapid Antibody Response after Vaccination with a Virosomal Hepatitis A Vaccine
F. Ambrosch (2004)
10.1177/030089160308900302
From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy
L. Cattel (2003)
evaluation in vitro and in vivo
C. P. Leamon (2003)
10.1517/14712598.4.7.1139
Influenza virosomes as an efficient system for adjuvanted vaccine delivery
R. Glueck (2004)
10.1016/S0304-3835(03)00097-1
Immunoliposomal fenretinide: a novel antitumoral drug for human neuroblastoma.
L. Raffaghello (2003)
10.1016/J.JCONREL.2003.08.019
Oral colon-specific drug delivery for bee venom peptide: development of a coated calcium alginate gel beads-entrapped liposome.
L. Xing (2003)
doxorubicinloaded long-circulating liposomes modified with anti-cancer antibody
A. N. Lukyanov (2004)
10.1097/00004424-199309000-00019
Preparation and Evaluation of Lyophilized Iopromide‐Carrying Liposomes for Liver Tumor Detection
A. Sachse (1993)
10.1073/PNAS.88.13.5572
Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis.
C. P. Leamon (1991)
10.1016/S0014-5793(02)02821-1
Anti‐neovascular therapy by liposomal DPP‐CNDAC targeted to angiogenic vessels
T. Asai (2002)
Folate receptor targeted delivery of liposomal daunorubicin into tumor cells.
Sandy Ni (2002)
10.1023/A:1016466406176
Transdermal Delivery of Pergolide from Surfactant-Based Elastic and Rigid Vesicles: Characterization and in Vitro Transport Studies
P. Honeywell-Nguyen (2004)
10.1016/S0378-5173(01)00579-8
Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat.
M. Kisel (2001)
10.1016/S0959-8049(01)00216-7
Phase II study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck.
K. Harrington (2001)
10.1016/S0168-3659(03)00242-6
VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies.
S. Dagar (2003)
10.1016/J.JCONREL.2003.10.024
Serum-stable and long-circulating, PEGylated, pH-sensitive liposomes.
Emmanuelle Roux (2004)
10.1002/jgm.358
Antibody targeted gene transfer to endothelium
P. Tan (2003)
10.1016/S0169-409X(00)00069-7
Virosomes: evolution of the liposome as a targeted drug delivery system.
Y. Kaneda (2000)
Practical Approach (Oxford
V. P. Torchilin (2003)
Liposomes containing interferon-γ as adjuvant in tumor cell vaccines
van Slooten (2000)
10.3892/IJO.20.1.181
Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes.
A. Derycke (2002)
10.1016/J.JCONREL.2004.03.030
Intracellular target for photosensitization in cancer antiangiogenic photodynamic therapy mediated by polycation liposome.
Y. Takeuchi (2004)
encapsulation and distribution studies
Xu (1990)
Liposomes as targetable drug carriers.
V. Torchilin (1985)
10.1016/S0959-8049(01)00329-X
Caelyx: phase II studies in ovarian cancer.
S. Johnston (2001)
10.1016/S0024-3205(01)01392-3
Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors.
N. Shibuya-Fujiwara (2001)
Freezy - drying of liposomes : theory and practice
E. C. van Winden (2003)
a kinetic and efficacy study
Y. L. Tseng (2002)
Polyethylene glycolcoated liposomes for oral delivery of recombinant human epidermal growth factor
H. Li (2003)
Practical Approach (eds Torchilin, V
V. P. Torchilin (2003)
10.1016/J.YGYNO.2003.12.037
A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.
M. Seiden (2004)
Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo.
C. M. Lee (2002)
10.1016/J.JACC.2003.11.054
Preservation of ischemic myocardial function and integrity with targeted cytoskeleton-specific immunoliposomes.
Tala Khudairi (2004)
9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
N. Koshkina (2000)
10.1097/01.WCB.0000072570.46552.DF
Antiactin-Targeted Immunoliposomes Ameliorate Tissue Plasminogen Activator-Induced Hemorrhage after Focal Embolic Stroke
M. Asahi (2003)
10.1016/S0168-3659(03)00093-2
Application of polyethyleneglycol (PEG)-modified liposomes for oral vaccine: effect of lipid dose on systemic and mucosal immunity.
Seiichiro Minato (2003)
studies in rat
Kisel (2001)
Surface-modified liposomes in γ and MRimaging
V. P. Torchilin (1997)
10.1089/089426804322994415
Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.
N. Koshkina (2004)
10.1080/10717540490280769
Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery
M. C. Taira (2004)
10.1016/S0163-7827(03)00033-X
Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.
S. Moghimi (2003)
10.1016/S0264-410X(02)00103-2
Virosome-mediated delivery of protein antigens to dendritic cells.
L. Bungener (2002)
Liposomes as Tools in Basic Research and Industry
J. Philippot (1994)
Sterically stabilized liposomes in cancer therapy and gene delivery.
Lasic Dd (1999)
10.1016/S0168-3659(02)00006-8
Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers.
P. Opanasopit (2002)
10.1002/JPS.10441
A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation.
A. Bao (2003)
10.1081/LPR-120017488
Liposomes: From the Bench to the Bed
D. J. Crommelin (2003)
10.1016/S0378-4274(03)00241-8
Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer.
A. Igarashi (2003)
10.1023/A:1007514424253
Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines
M. van Slooten (2004)
10.1248/CPB.50.749
Phospholipid deformable vesicles for buccal delivery of insulin.
Tian-zhi Yang (2002)
10.1073/pnas.151247498
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors
V. Torchilin (2001)
10.3109/02652049509087256
Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
C. K. Kim (1995)
10.1081/CNV-100103136
Pegylated Liposomal Doxorubicin: Metamorphosis of an Old Drug into a New Form of Chemotherapy
A. Gabizon (2001)
10.1016/S0076-6879(03)73005-5
Influenza virosomes in vaccine development.
A. Huckriede (2003)
Lymphatic delivery and pharmacokinetics of methotrexate to rats
C. K. Kim (1995)
10.1016/S0927-7765(99)00155-1
Long-circulating gadolinium-loaded liposomes: potential use for magnetic resonance imaging of the blood pool.
Weissig (2000)
10.1016/S0168-3659(01)00309-1
Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS.
H. Maeda (2001)
10.1007/BF00968993
Liposome-entrapped superoxide dismutase reduces ischemia/reperfusion ‘oxidative stress’ in gerbil brain
D. Stanimirovic (2004)
10.1016/S0169-409X(96)00472-3
Surface-modified liposomes in gamma- and MR-imaging
V. Torchilin (1997)
10.1080/003655202320378266
Hepatic Preservation, Liposomally Entrapped Adenosine Triphosphate and Nitric Oxide Production: a Study of Energy State and Protein Metabolism in the Cold-Stored Rat Liver
N. Neveux (2002)
10.1016/S0168-3659(01)00364-9
Intracytoplasmic gene delivery for in vitro transfection with cytoskeleton-specific immunoliposomes.
B. A. Khaw (2001)
10.1016/J.BBRC.2003.11.057
Cationic liposome-mediated delivery of siRNAs in adult mice.
M. Sioud (2003)
10.1021/JA0482536
Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells.
J. Rothbard (2004)
10.1089/HYB.1984.3.11
Monoclonal antibody to cardiac myosin: imaging of experimental myocardial infarction.
B. Khaw (1984)
from the bench to the bed
D. J. Crommelin (2003)
in vitro and in vivo evaluation
Bao (2003)
10.1016/J.JCONREL.2004.08.007
Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody.
A. Lukyanov (2004)
10.1016/S0264-410X(02)00536-4
Liposomal delivery of antigen to human dendritic cells.
M. J. Copland (2003)
10.1080/089583701753403980
9-NITROCAMPTOTHECIN LIPOSOME AEROSOL: LACK OF SUBACUTE TOXICITY IN DOGS
B. Gilbert (2002)
10.1016/0005-2736(93)90351-Y
Molecular mechanism of the lipid vesicle longevity in vivo.
G. Blume (1993)
10.1182/BLOOD.V100.2.594
Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
X. Q. Pan (2002)
effects of coating the liposome’s surface on the GI transport of insulin
Iwanaga (1999)
10.1073/pnas.0435906100
Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposome–DNA complexes
V. Torchilin (2003)
10.1211/0022357011775523
A novel and simple type of liposome carrier for recombinant interleukin‐2
E. Kanaoka (2001)
evolution of the liposome as a targeted drug delivery system
Kaneda (2000)
Application of surfacecoated liposomes for oral delivery of peptide : effects of coating the liposome ’ s surface on the GI transport of insulin
K. Iwanaga (1999)
10.1021/JS950349Y
Transdermal iontophoretic delivery of enkephalin formulated in liposomes.
N. B. Vutla (1996)
10.1002/cncr.11593
Multicenter study of pegylated liposomal doxorubicin in patients with cutaneous T‐cell lymphoma
U. Wollina (2003)
10.1615/CRITREVTHERDRUGCARRIERSYST.V15.I5.10
The potential of liposomes in oral drug delivery.
J. Rogers (1998)
10.1007/s15010-004-3204-z
Open, Randomized Study to Compare the Immunogenicity and Reactogenicity of an Influenza Split Vaccine with an MF59-Adjuvanted Subunit Vaccine and a Virosome-Based Subunit Vaccine in Elderly
B. Ruf (2004)
10.1086/377542
Single-dose liposomal amphotericin B in the treatment of visceral leishmaniasis in India: a multicenter study.
S. Sundar (2003)
10.1081/CNV-120016412
Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*
K. Skubitz (2003)
recent experience with tumor-targeted, stericallystabilized immunoliposomes and active-loading gradients
Abra (2002)
10.1016/b978-0-444-82917-7.x5000-5
Medical applications of liposomes
D. Lasič (1998)
10.1016/S0169-409X(02)00042-X
Folate-mediated delivery of macromolecular anticancer therapeutic agents.
Y. Lu (2002)
10.1016/J.VACCINE.2003.08.024
Efficient delivery of DNA to dendritic cells mediated by influenza virosomes.
M. G. Cusi (2004)
10.1021/BC0340363
A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity.
J. Metselaar (2003)
10.1002/ijc.20035
Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet
H. Nobuto (2004)
10.1016/0014-5793(90)81016-H
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
A. Klibanov (1990)
10.1016/S0169-409X(01)00209-5
Cell-specific delivery of genes with glycosylated carriers.
M. Hashida (2001)
10.1067/MAI.2003.104
Efficacy of liposomal budesonide in experimental asthma.
K. Konduri (2003)
Liposome Technology vol. 1–3 (CRC
Gregoriadis (1984)
10.1021/BC025546K
Effect of Hb-encapsulation with vesicles on H2O2 reaction and lipid peroxidation.
S. Takeoka (2002)
10.1081/LPR-100108459
POLY(HPMA)-COATED LIPOSOMES DEMONSTRATE PROLONGED CIRCULATION IN MICE
K. Whiteman (2001)
10.1016/J.ADDR.2003.10.038
On the formulation of pH-sensitive liposomes with long circulation times.
S. Simões (2004)
10.1097/00001813-200010000-00002
Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
M. Schwonzen (2000)
10.1023/A:1016030202104
Lectin-bearing Polymerized Liposomes as Potential Oral Vaccine Carriers
Hongming Chen (2004)
influence of O2 affinity
Sakai (1999)
a comparison with free t-PA, Thromb
Heeremans (1995)
10.1007/978-3-662-22115-0
Long Circulating Liposomes: Old Drugs, New Therapeutics
M. Woodle (1998)
10.1007/s00262-002-0266-6
Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors
Y. Lu (2002)
10.1016/S0378-5173(02)00129-1
Liposome clearance in mice: the effect of a separate and combined presence of surface charge and polymer coating.
T. Levchenko (2002)
Practical Approach (eds Torchilin, V
A. L. Klibanov (2003)
Liposomes: From Physics to Applications
D. Lasič (1993)
Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy.
Stacy M Stephenson (2003)
10.1016/S0264-410X(03)00509-7
Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal).
V. Usonis (2003)
Folate - liposomemediated antisense oligodeoxynucleotide targeting to cancer cells : evaluation in vitro and in vivo
C. P. Leamon (2003)
Influenza virosomes in vaccine
A. Huckriede (2003)
Stealth Liposomes (CRC
F. Martin (1995)
10.1074/JBC.M200429200
Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped Proteins*
E. Mastrobattista (2002)
10.1016/S0005-2728(01)00165-7
p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups.
V. Torchilin (2001)
10.1002/ijc.10548
Targeting of the photocytotoxic compound AlPcS4 to hela cells by transferrin conjugated peg‐liposomes
A. Gijsens (2002)
Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes.
L. Xu (2002)
10.1016/S0168-3659(01)00315-7
Tumor targeting using anti-her2 immunoliposomes.
J. Park (2001)
10.1097/00004424-199701000-00007
Biodistribution and computed tomography blood-pool imaging properties of polyethylene glycol-coated iopromide-carrying liposomes.
A. Sachse (1997)
10.1023/A:1020198908574
Delivery of Protein Antigens to the Immune System by Fusion-Active Virosomes: A Comparison with Liposomes and ISCOMs
L. Bungener (2002)
10.1038/sj.gt.3301833
Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors
J. Reddy (2002)
effect of dose
T. M. Allen (1991)
Liposomal delivery of antigens to human dendritic cells
Copland (2003)
10.1016/J.IJPHARM.2003.08.017
Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
S. Vyas (2004)
10.1016/0005-2736(93)90039-3
Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times.
G. Blume (1993)
10.1016/S0021-9258(17)41848-5
Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis.
R. Lee (1994)
10.4049/jimmunol.167.11.6462
Efficient Delivery of Antennapedia Homeodomain Fused to CTL Epitope with Liposomes into Dendritic Cells Results in the Activation of CD8+ T Cells
G. Chikh (2001)
10.1021/BC990173H
Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state.
H. Sakai (2000)
10.1016/0005-2736(94)90003-5
Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity.
V. Torchilin (1994)
in vivo studies
S. Dagar (2003)
10.1016/0169-409X(95)00022-Y
Which polymers can make nanoparticulate drug carriers long-circulating?
V. Torchilin (1995)
10.1002/ijc.10242
Intracellular targeting therapy of cisplatin‐encapsulated transferrin‐polyethylene glycol liposome on peritoneal dissemination of gastric cancer
H. Iinuma (2002)
10.1016/J.JCONREL.2003.09.019
Liposomes and disaccharides as carriers in spray-dried powder formulations of superoxide dismutase.
Y. Lo (2004)
10.1054/bjoc.2001.2149
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma
M. Schmidinger (2001)
10.1016/S0168-3659(02)00017-2
Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations.
Guangfeng Shi (2002)
10.1016/S0005-2736(02)00399-1
A novel pH-sensitive liposome formulation containing oleyl alcohol.
J. Sudimack (2002)
10.1002/(SICI)1097-0142(19990701)86:1<72::AID-CNCR12>3.0.CO;2-1
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes
Z. Symon (1999)
10.1016/S0378-5173(98)00408-6
Pharmacodynamics of insulin in polyethylene glycol-coated liposomes.
A. Kim (1999)
10.1002/ijc.11615
Loading mitomycin C inside long circulating hyaluronan targeted nano‐liposomes increases its antitumor activity in three mice tumor models
D. Peer (2004)
10.1097/00000542-200407000-00021
A Novel Liposomal Bupivacaine Formulation to Produce Ultralong-Acting Analgesia
G. J. Grant (2004)
illustration of targeted delivery
Vigilanti (2004)
10.1023/A:1022656105022
Antitumor Activity of Folate Receptor-Targeted Liposomal Doxorubicin in a KB Oral Carcinoma Murine Xenograft Model
X. Q. Pan (2004)
10.1016/S1043-6618(02)00312-2
In vivo photosensitizing efficiency of a diphenylchlorin sensitizer: interest of a DMPC liposome formulation.
L. Bourré (2003)
10.1038/nm1195-1195
Plug and seal: Prevention of hypoxic cardiocyte death by sealing membrane lesions with antimyosin-liposomes
B. Khaw (1995)
10.1016/S0924-8579(02)00021-3
Long-circulating sterically stabilized liposomes as carriers of agents for treatment of infection or for imaging infectious foci.
I. Bakker-Woudenberg (2002)
10.1111/j.1348-0421.2002.tb02677.x
Oral Delivery of Antigens in Liposomes with Some Lipid Compositions Modulates Oral Tolerance to the Antigens
K. Masuda (2002)
10.1016/0005-2736(91)90201-I
Pharmacokinetics of stealth versus conventional liposomes: effect of dose.
T. Allen (1991)
10.1248/BPB.23.97
Magnetic resonance lymphography of profundus lymph nodes with liposomal gadolinium-diethylenetriamine pentaacetic acid.
Y. Fujimoto (2000)
10.3816/CBC.2003.N.037
Pegylated liposomal doxorubicin in the treatment of breast cancer.
J. O'Shaughnessy (2003)
10.2139/SSRN.288539
[The theory and the practice...].
T. Frankel (2007)
Liposomal atp or NAD+ protects human endothelial cells from energy failure in a cell culture model of sepsis.
Y. Han (2001)
10.1055/S-0038-1653802
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA.
J. Heeremans (1995)
10.1179/016164103101201508
Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin
N. Omori (2003)
10.1016/S0168-3659(01)00368-6
Evaluation of circulation profiles of liposomes coated with hydrophilic polymers having different molecular weights in rats.
H. Takeuchi (2001)
10.1016/J.JCONREL.2005.08.029
ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model.
D. Verma (2005)
10.1016/S0264-410X(02)00508-X
Virosome influenza vaccine in children.
C. Herzog (2002)
Liposomal targeting through peptide-amphiphile functionalization
R. Tu (2004)
10.1016/S0264-410X(00)00163-8
In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity.
B. Ludewig (2000)
10.1515/znc-2000-3-422
Site-Specific in vivo Targeting of Magnetoliposomes Using Externally Applied Magnetic Field
M. Babincová (2000)
10.1016/S0169-409X(01)00154-5
Liposomes to target the lymphatics by subcutaneous administration.
C. Oussoren (2001)
10.1016/S0168-3659(02)00264-X
A facile method of delivery of liposomes by nebulization.
T. Desai (2002)
10.3109/10611860008997902
Uptake of Long-Circulating Immunoliposomes, Directed Against Colon Adenocarcinoma Cells, by Liver Metastases of Colon Cancer
J. Kamps (2000)
10.1016/S0378-5173(03)00158-3
Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
H. Li (2003)
10.1016/0024-3205(77)90481-7
Liposomes as drug carriers.
J. H. Fendler (1977)
10.1002/ijc.10857
Experimental photodynamic therapy with MESO‐tetrakisphenylporphyrin (TPP) in liposomes leads to disintegration of human amelanotic melanoma implanted to nude mice
P. Jezek (2003)
10.1016/S0168-3659(03)00240-2
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin.
R. Schiffelers (2003)
10.1016/S0005-2736(01)00369-8
New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes.
G. Cevc (2001)
10.1016/S0959-440X(00)00230-X
Structures of lipid-DNA complexes: supramolecular assembly and gene delivery.
C. Safinya (2001)
10.1007/s002800050497
Biological characterization of L-asparaginase liposomal formulations
M. M. Gaspar (1996)
10.1016/S0168-3659(03)00160-3
Potentiality of double liposomes containing salmon calcitonin as an oral dosage form.
Kenji Yamabe (2003)
10.1081/LPR-120017484
Emerging Role of Liposomal Drug Carrier Systems in Cancer Chemotherapy
A. Gabizon (2003)
10.1002/IJC.2910370123
Treatment of murine L1210 lymphoid leukemia and melanoma B16 with lipophilic cytosine arabinoside prodrugs incorporated into unilamellar liposomes
W. Rubas (1986)
Structures of lipidDNA complexes : supramolecular assembly and gene delivery
C. R. Safinya (2001)
10.1016/S0076-6879(03)67008-4
Freeze-drying of liposomes: theory and practice.
E. C. V. Winden (2003)
10.2174/1389201003378960
Polymeric contrast agents for medical imaging.
V. Torchilin (2000)
10.1016/S0264-410X(99)00054-7
Comparison of the quality of protection elicited by toxoid and peptide liposomal vaccine formulations against ricin as assessed by markers of inflammation.
G. Griffiths (1999)
10.1016/S0005-2736(03)00050-6
Cytosolic delivery of macromolecules. II. Mechanistic studies with pH-sensitive morpholine lipids.
A. Asokan (2003)
10.1016/S0142-9612(01)00050-3
Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification.
V. Torchilin (2001)
10.1023/A:1015837321087
Adenosine Triphosphate Liposomes: Encapsulation and Distribution Studies
Xu Guo-Xing (2004)
10.1089/10430340260355392
Transferrin-facilitated lipofection gene delivery strategy: characterization of the transfection complexes and intracellular trafficking.
N. Joshee (2002)
10.1002/BIOF.5520090228
Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury
K. Niibori (1999)
10.1016/J.ADDR.2003.10.037
"Smart" delivery of antisense oligonucleotides by anionic pH-sensitive liposomes.
E. Fattal (2004)
10.1016/0092-8674(88)90263-2
Cellular uptake of the tat protein from human immunodeficiency virus
A. Frankel (1988)
10.1016/S0076-6879(03)73013-4
Liposomes in ultrasound and gamma scintigraphic imaging.
S. Dagar (2003)
10.1023/A:1020989709019
In Vivo Characteristics of Cationic Liposomes as Delivery Vectors for Gene Therapy
S. Audouy (2004)
10.1096/fasebj.6.9.1612296
Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium
V. Torchilin (1992)
10.1016/J.ADDR.2003.07.014
Liposomes for photodynamic therapy.
A. Derycke (2004)
Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice.
Z. Wu (2004)
10.1038/nm996
Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis
J. Wadia (2004)
10.1023/A:1022608321861
Liposome-Mediated Targeting of Enzymes to Cancer Cells for Site-Specific Activation of Prodrugs: Comparison with the Corresponding Antibody-Enzyme Conjugate
M. J. Fonseca (2004)
10.1586/14760584.2.2.189
Virosomal adjuvanted antigen delivery systems
C. Moser (2003)
10.1021/JS980235X
Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin.
K. Iwanaga (1999)
186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
A. Bao (2003)
10.1016/J.CANLET.2003.10.001
Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
K. Ichikawa (2004)
10.1073/PNAS.93.24.14164
Brain drug delivery of small molecules using immunoliposomes.
J. Huwyler (1996)
10.1159/000129451
Liposomal ATP protects the liver from injury during shock.
H. Konno (1996)
10.1152/ajpheart.1999.276.2.H553
Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity.
H. Sakai (1999)
Sterically stabilized liposomes in cancer therapy and gene delivery.
D. Lasic (1999)
10.1016/S0304-3835(03)00107-1
Targeted delivery system for antisense oligonucleotides: a novel experimental strategy for neuroblastoma treatment.
C. Brignole (2003)
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
N. Postma (1999)
10.1016/S0005-2736(03)00109-3
Polycation liposome-mediated gene transfer in vivo.
M. Matsuura (2003)
10.1124/JPET.103.060228
Neutral and Anionic Liposome-Encapsulated Hemoglobin: Effect of Postinserted Poly(ethylene glycol)-distearoylphosphatidylethanolamine on Distribution and Circulation Kinetics
V. Awasthi (2004)
10.1385/1-59259-175-2:163
Targeted gene delivery by virosomes.
D. Sarkar (2002)
Immobilized Enzymes in Medicine (Springer–Verlag
V. P. Torchilin (1991)
Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs.
P. Sapra (2002)
10.1023/A:1020151025412
Liposomal Delivery of CTL Epitopes to Dendritic Cells
Ghania Chikh (2002)
10.1016/S0169-409X(99)00064-2
Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.
M. Rao (2000)
10.1016/J.JCONREL.2004.04.015
Biodistribution of pH-responsive liposomes for MRI and a novel approach to improve the pH-responsiveness.
K. Løkling (2004)
10.1002/mrm.20074
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery
B. Viglianti (2004)
10.1080/14733400410001727592
Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
C. Mamot (2003)
10.1016/S0168-3659(01)00505-3
Surface modification of liposomes for selective cell targeting in cardiovascular drug delivery.
B. J. Lestini (2002)
10.1081/LPR-120004770
THE NEXT GENERATION OF LIPOSOME DELIVERY SYSTEMS: RECENT EXPERIENCE WITH TUMOR-TARGETED, STERICALLY-STABILIZED IMMUNOLIPOSOMES AND ACTIVE-LOADING GRADIENTS
R. Abra (2002)
10.1016/J.ADDR.2003.10.028
Lipid vesicles and other colloids as drug carriers on the skin.
G. Cevc (2004)
Novel method of greatly enhanced delivery of liposomes to lymph nodes.
W. Phillips (2000)
10.1007/978-3-642-75821-8
Immobilized Enzymes in Medicine
Ph.D. Dr. Sci. Vladimir P. Torchilin (1991)
coupling of homing devices to the ends of polymeric chains combines effective target binding with long circulation times
Blume (1993)



This paper is referenced by
10.1016/j.ijpharm.2008.04.004
Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers.
Tamer M Shehata (2008)
10.1615/CRITREVTHERDRUGCARRIERSYST.V26.I6.10
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
A. Puri (2009)
10.1007/s11095-011-0619-y
Sterically Stabilized Liposomes Incorporating the Novel Anticancer Agent Phospho-Ibuprofen (MDC-917): Preparation, Characterization, and In Vitro/In Vivo Evaluation
George Mattheolabakis (2011)
10.1039/c3nr03698g
pH-responsive gold nanoparticles-in-liposome hybrid nanostructures for enhanced systemic tumor delivery.
Jutaek Nam (2013)
10.1016/j.biomaterials.2013.07.003
Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
S. Aryal (2013)
10.1016/j.ddtec.2012.01.003
siRNA as a conventional drug in the clinic? Challenges and current technologies.
M. Shim (2012)
10.1080/17425247.2017.1317245
Porous silicon for drug delivery applications and theranostics: recent advances, critical review and perspectives
Tushar Kumeria (2017)
10.1016/j.ultrasmedbio.2013.02.010
Ultrasound improves the uptake and distribution of liposomal Doxorubicin in prostate cancer xenografts.
Siv Eggen (2013)
10.1109/ULTSYM.2011.0372
Intracellular delivery of nanoparticles using ultrasound
Mercy Afadzi (2011)
10.1016/J.PROGPOLYMSCI.2013.06.009
Biomedical applications and colloidal properties of amphiphilically modified chitosan hybrids
M. Larsson (2013)
10.1039/c2cc33543c
pH-responsive NIR enhanced drug release from gold nanocages possesses high potency against cancer cells.
P. Shi (2012)
Development of photosensitive liposomes for the controlled release of drugs
Pranav Bhujbal (2016)
10.1039/C2NJ20997G
Phenylboronic acid-containing block copolymers: synthesis, self-assembly, and application for intracellular delivery of proteins
Cui Cheng (2012)
10.1002/marc.201100863
Synthesis of porous PEG microgels using CaCO3 microspheres as hard templates.
Muriel Behra (2012)
10.1007/s00775-012-0907-y
Interaction of liposome-encapsulated cisplatin with biomolecules
Bharat Baruah (2012)
10.1039/c6nr03940e
Enhanced protein internalization and efficient endosomal escape using polyampholyte-modified liposomes and freeze concentration.
Sana Ahmed (2016)
10.1039/c3sm52866a
Supra-amphiphilic aggregates formed by p-sulfonatocalix[4]arenes and the antipsychotic drug chlorpromazine.
Z. Qin (2014)
10.1038/ncomms15507
Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy
Y. Su (2017)
10.1007/s10311-018-00841-1
Nanocarriers for drug delivery applications
M. Chamundeeswari (2018)
10.1016/j.talanta.2018.10.101
Facile preparation of metal-organic frameworks-based hydrophobic anticancer drug delivery nanoplatform for targeted and enhanced cancer treatment.
K. Dong (2019)
10.1007/978-3-030-26736-0_1
Production of Phage Therapeutics and Formulations: Innovative Approaches
Maia Merabishvili (2019)
10.1007/978-3-030-06115-9_5
Stealth Properties of Nanoparticles Against Cancer: Surface Modification of NPs for Passive Targeting to Human Cancer Tissue in Zebrafish Embryos
S. A. Adeyemi (2019)
10.1007/s42770-018-0035-0
Nano-multilamellar lipid vesicles (NMVs) enhance protective antibody responses against Shiga toxin (Stx2a) produced by enterohemorrhagic Escherichia coli strains (EHEC)
M. J. Rodrigues-Jesus (2019)
10.1016/j.ijpharm.2018.12.030
Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: State of the art review.
Michaela Breitsamer (2019)
10.1016/j.addr.2019.07.002
Integrating nanomedicine into clinical radiotherapy regimens.
Allison N DuRoss (2019)
10.1016/j.nano.2016.05.008
The ligand (s) anchored lipobrid nanoconstruct mediated delivery of methotrexate: an effective approach in breast cancer therapeutics.
N. Garg (2016)
10.1016/j.carbpol.2016.10.063
Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery.
Sonia Alavi (2017)
10.1016/j.jconrel.2016.01.002
Ligand-targeted theranostic nanomedicines against cancer.
V. J. Yao (2016)
10.1016/B978-0-323-41533-0.00013-1
Nanobiomaterials: Applications in biomedicine and biotechnology
T. Singh (2016)
10.1002/wnan.1347
Near-infrared light-responsive nanomaterials for cancer theranostics.
Heejung Kim (2016)
10.1016/J.ADDR.2007.10.008
Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
V. Torchilin (2008)
Monoclonal Antibody and Liposomal Nanoparticle-based Targeting Therapies for Chronic Lymphocytic Leukemia
Y. Mao (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar